Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
2013 · JNCI Journal of the National Cancer Institute · 222 citations
https://doi.org/10.1093/jnci/djt235
R
Ruediger Ridder
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
4.5K
Citations
30
h-index
38
i10-index
Ruediger Ridder is an academic researcher from Roche Pharma AG (Germany). The author has contributed to research in topics: Cervical Cancer and HPV Research & Head and Neck Cancer Studies & Cancer-related Molecular Pathways. The author has an h-index of 30, co-authored 40 publications.
Papers by this author
worksRoutine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation
2018 · The American Journal of Surgical Pathology · 43 citations
https://doi.org/10.1097/pas.0000000000001072
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
2022 · BMC Infectious Diseases · 22 citations
https://doi.org/10.1186/s12879-022-07654-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat